An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease

Archives of Neurology

Volumn 67, Issue 5, 2010, Pages 536-541

  Roses, Allen D ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; CHROMOSOME 19; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MITOCHONDRIAL TOXICITY; ONSET AGE; PARSIMONY ANALYSIS; PHYLOGENY; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TOMM40 GENE;

AGE OF ONSET; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CHROMOSOMES, HUMAN, PAIR 19; DNA REPEAT EXPANSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC;

EID: 77952187277     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.88     Document Type: Review

References (14)

1. Eastman P. Safe ways to speed CNS drugs to patients, including provisional approval. Neurology Today. 2009;8(7):6. doi:10.1038/tpj.2009.69.
2. Avramopoulos D. Genetics of Alzheimer's disease: recent advances. Genome Med. 2009;1(3):34. doi:10.1186/gm34.
3. Roses AD, Lutz MW, Amrine-Madsen H, et al. A TOMM40 variable length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J. http://www.nature.com/tpj/journal/vaop/ncurrent/abs/ tpj200969a.html. In press.
4. Anandatheerthavarada HK, Biswas G, Robin M-A, Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol. 2003;161(1):41-54. (Pubitemid 36459078)
5. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci. 2006;26(35):9057-9068. (Pubitemid 44319397)
6. Liang WS, Reiman EM, Valla J, et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci U S A. 2008;105(11):4441-4446.
7. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921-923.
8. Brodbeck J, Balestra M, Freedman S, Weisgraber KH, Mahley RW, Huang Y. Apolipoprotein E4 and its fragment impair mitochondrial dynamics in neuronal cultures. Alzheimers Dement. 2008;4(4)(suppl 1):T163.
9. Brodbeck J, Balestra ME, Saunders AM, Roses AD, Mahley RW, Huang Y. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc Natl Acad Sci U S A. 2008;105(4):1343-1346. (Pubitemid 351397055)
10. Brodbeck J, Miranda RD, Freedman SB, Weisgraber KH, Mahley RW, Huang Y. Apolipoprotein E4 impairs mitochondrial function and increases reactive oxygen species in neuronal cells. Alzheimers Dement. 2009;5(4)(suppl 1):307. doi:10.1016/j.jalz.2009.04.469.
11. Chang S, ran Ma T, Miranda RD, Balestra ME, Mahley RW, Huang Y. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci U S A. 2005;102(51):18694-18699.
12. Goedert M, Spillantini MG. A century of Alzheimer's disease. Science. 2006;314(5800):777-781.
13. Roses AD, Saunders AM. Perspective on a pathogenesis and treatment of Alzheimer's disease. Alzheimers Dement. 2006;2(2):59-70.
14. Zinfandel Pharmaceuticals Inc. Opportunity for the Prevention of Alzheimer's Web site. http://www.opalstudy.org. Accessed February 11, 2010.